Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Petrelli, F; Rulli, E; Labianca, R; Lonardi, S; Rosati, G; Dotti, K; Ronzoni, M; Pella, N; Pusceddu, V; Banzi, M; Zampino, M G; Yasmina, M; Marchetti, P; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Zagonel, V; Maiello, E; Sobrero, A.

Ann Oncol ; 32(1): 66-76, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-33098997

2.

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.

Lonardi, S; Sobrero, A; Rosati, G; Di Bartolomeo, M; Ronzoni, M; Aprile, G; Massida, B; Scartozzi, M; Banzi, M; Zampino, M G; Pasini, F; Marchetti, P; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Barni, S; Zagonel, V; Maiello, E; Rulli, E; Labianca, R.

Ann Oncol ; 27(11): 2074-2081, 2016 11.

Artículo en Inglés | MEDLINE | ID: mdl-27573560

3.

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.

Bajetta, E; Floriani, I; Di Bartolomeo, M; Labianca, R; Falcone, A; Di Costanzo, F; Comella, G; Amadori, D; Pinto, C; Carlomagno, C; Nitti, D; Daniele, B; Mini, E; Poli, D; Santoro, A; Mosconi, S; Casaretti, R; Boni, C; Pinotti, G; Bidoli, P; Landi, L; Rosati, G; Ravaioli, A; Cantore, M; Di Fabio, F; Aitini, E; Marchet, A.

Ann Oncol ; 25(7): 1373-1378, 2014 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-24728035

4.

The role of adjuvant chemotherapy in colon cancer.

Labianca, R; Milesi, L; Mosconi, S; Pessi, M A; Beretta, G D; Quadri, A.

Surg Oncol ; 16 Suppl 1: S93-6, 2007 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-18257148

5.

New strategies in colon cancer adjuvant therapy.

Labianca, R; Mosconi, S; Garassino, M C.

Ann Oncol ; 17 Suppl 7: vii51-4, 2006 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-16760294

6.

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer.

Lise, M; Nitti, D; Marchet, A; Sahmoud, T; Buyse, M; Duez, N; Fiorentino, M; Dos Santos, J G; Labianca, R; Rougier, P.

J Clin Oncol ; 13(11): 2757-63, 1995 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-7595735

7.

High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratio.

Labianca, R; Pancera, G; Tedeschi, L; Dallavalle, G; Luporini, A; Luporini, G.

Tumori ; 78(1): 32-4, 1992 Feb 29.

Artículo en Inglés | MEDLINE | ID: mdl-1609456

8.

[Current status of the use of vitamins (A, E, C, D), folates and selenium in the chemoprevention and treatment of malignant tumors]. / Stato attuale dell'impiego di vitamine (A, E, C, D), folati e selenio nella chemioprevenzione e nel trattamento dei tumori maligni.

Clerici, M; Pastorino, U; Labianca, R; Vergani, C; Pancera, G; De Benedictis, R.

Minerva Med ; 78(6): 377-86, 1987 Mar 31.

Artículo en Italiano | MEDLINE | ID: mdl-3561847

9.

[Adjuvant chemotherapy in colon cancer: certainties and questions] . / La chemioterapia adiuvante del carcinoma cel colon: certezze e interrogativi.

Labianca, R; Beretta, G D; Pessi, M A; Poletti, P.

Tumori ; 86(4): A1-3, 2000.

Artículo en Italiano | MEDLINE | ID: mdl-11182988

10.

[Adjuvant therapy of colon cancer. State of the art and future perspectives]. / Trattamento adiuvante del carcinoma del colon. Stato dell'arte e prospettive future.

Barni, S; Cascinu, S; Foa, P; Frontini, L; Labianca, R; Luporini, G; Mandalà, M; Martignoni, G; Pancera, G; Sobrero, A; Zaniboni, A.

Tumori ; 85(3): A1-6, 1999.

Artículo en Italiano | MEDLINE | ID: mdl-10426137

11.

Adjuvant therapy for stage II colon cancer: an elephant in the living room?

Zaniboni, A; Labianca, R.

Ann Oncol ; 15(9): 1310-8, 2004 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-15319235

12.

Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives.

Wils, J; O'Dwyer, P; Labianca, R.

Ann Oncol ; 12(1): 13-22, 2001 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-11249040

13.

Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors.

Cascinu, S; Georgoulias, V; Kerr, D; Maughan, T; Labianca, R; Ychou, M.

Ann Oncol ; 14 Suppl 2: ii25-9, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-12810454

14.

GIVIO-SITAC 01: A randomized trial of adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon.

Zaniboni, A; Labianca, R; Marsoni, S; Torri, V; Mosconi, P; Grilli, R; Apolone, G; Cifani, S; Tinazzi, A.

Cancer ; 82(11): 2135-44, 1998 Jun 01.

Artículo en Inglés | MEDLINE | ID: mdl-9610692

15.

Prognostic factors in resectable gastric cancer: results of EORTC study no. 40813 on FAM adjuvant chemotherapy.

Lise, M; Nitti, D; Marchet, A; Sahmoud, T; Duez, N; Fornasiero, A; dos Santos, J G; Labianca, R; Lasser, P; Gignoux, M.

Ann Surg Oncol ; 2(6): 495-501, 1995 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-8591079

16.

A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.

Cascinu, S; Graziano, F; Barni, S; Labianca, R; Comella, G; Casaretti, R; Frontini, L; Catalano, V; Baldelli, A M; Catalano, G.

Br J Cancer ; 84(4): 470-4, 2001 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11207039

17.

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.

Sargent, D J; Goldberg, R M; Jacobson, S D; Macdonald, J S; Labianca, R; Haller, D G; Shepherd, L E; Seitz, J F; Francini, G.

N Engl J Med ; 345(15): 1091-7, 2001 Oct 11.

Artículo en Inglés | MEDLINE | ID: mdl-11596588

18.

Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. European Organisation for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group, the Gruppo Interdisciplinare Valutazione Interventi in Oncologia, and the Japanese Foundation for Cancer Research.

Rougier, P; Sahmoud, T; Nitti, D; Curran, D; Doci, R; De Waele, B; Nakajima, T; Rauschecker, H; Labianca, R; Pector, J C; Marsoni, S; Apolone, G; Lasser, P; Couvreur, M L; Wils, J.

Lancet ; 351(9117): 1677-81, 1998 Jun 06.

Artículo en Inglés | MEDLINE | ID: mdl-9734883

19.

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

Rougier, P; Van Cutsem, E; Bajetta, E; Niederle, N; Possinger, K; Labianca, R; Navarro, M; Morant, R; Bleiberg, H; Wils, J; Awad, L; Herait, P; Jacques, C.

Lancet ; 352(9138): 1407-12, 1998 Oct 31.

Artículo en Inglés | MEDLINE | ID: mdl-9807986

20.

Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy.

Passalacqua, R; Campione, F; Caminiti, C; Salvagni, S; Barilli, A; Bella, M; Barni, S; Barsanti, G; Caffo, O; Carlini, P; Cinquemani, G; Di Costanzo, F; Giustini, L; Labianca, R; Mazzei, A; Olmeo, N; Paccagnella, A; Toscano, L; Cocconi, G.

Lancet ; 353(9161): 1310-4, 1999 Apr 17.

Artículo en Inglés | MEDLINE | ID: mdl-10218529

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: